Gene · 1642
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis of diverse substrate recruitment by the HIV-1 Vpr-hijacked CRL4(VprBP) E3 ligase. | PLoS Pathog | 2026 | 42821551 | PubTator, text mining | PubMed |
Lipid Conjugation of a Photoprotective Meadowfoam (Limnanthes alba) Glucolimnanthin Derivative Reduces Cytotoxicity, Attenuates UV-Induced DNA Damage and Activates DNA Repair in Human Keratinocytes Following UV Radiation. | Biomolecules | 2026 | 42650817 | PubTator, text mining | PubMed |
| Ubiquitin-dependent control of PD-L1 nuclear translocation by DDB1 dictates anti-PD-1 response. | Sci Bull (Beijing) | 2026 | 42608270 | PubTator, text mining | PubMed |
| HBx Downregulates TFEB via the CUL4A/CUL4B-DDB1 Axis to Disrupt Lysosomal Function in Hepatocellular Carcinoma Cells. | Cells | 2026 | 42505369 | PubTator, text mining | PubMed |
| CRISPR/Cas9 screen identifies DCAF4 as a novel protector of hepatocellular carcinoma against brachytherapy via stress granule-dependent NRF2 activation. | Cell Death Dis | 2026 | 42449099 | PubTator, text mining | PubMed |
| Synthesis of Nitazoxanide Derivatives as Potent and Orally Available HBx-DDB1 Inhibitors against Hepatitis B Virus. | ACS Med Chem Lett | 2026 | 42445001 | PubTator, text mining | PubMed |
| DCAF13 is associated with pancreatic ductal adenocarcinoma progression and p53-related signaling in TP53-mutant cells. | Biochem Biophys Res Commun | 2026 | 42361739 | PubTator, text mining | PubMed |
| UV-DDB as a Dynamic Regulator Linking Base Excision and Nucleotide Excision Repair via AAG Interaction. | Int J Mol Sci | 2026 | 42353235 | PubTator, text mining | PubMed |
| Beyond KEAP1: The Context-Specific NRF2 Partner Code in Disease and Therapy. | Antioxidants (Basel) | 2026 | 42352065 | PubTator, text mining | PubMed |
| Structural basis for selective and potent degradation of IRAK4 by KT-474. | Nat Commun | 2026 | 42336816 | PubTator, text mining | PubMed |
| TDTAC: a generalized time-dependent torsion angle correlation framework for resolving directional coordination in large biomolecular assemblies. | Front Mol Biosci | 2026 | 42311447 | PubTator, text mining | PubMed |
| BR-FDP-SKIN: Brazilian forensic DNA Skin phenotyping based on machine learning models. | Forensic Sci Int | 2026 | 42308827 | PubTator, text mining | PubMed |
| From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer. | Front Immunol | 2026 | 42292383 | PubTator, text mining | PubMed |
| Woodhouse-Sakati Syndrome Due to the Rare DCAF17 c.321+1G>A Mutation: The Second Case Report Worldwide. | Cureus | 2026 | 42255876 | PubTator, text mining | PubMed |
| microRNA miR-31-5p confers protection to melanin-deficient vitiligo keratinocytes against UV-B induced DNA damage by activating autophagy machinery. | Sci Rep | 2026 | 42230707 | PubTator, text mining | PubMed |
| DCAF8 binds DDB1 via an N-terminal helix-loop-helix motif to assemble CRL4 and promote cell cycle progression. | Cell Rep | 2026 | 42228576 | PubTator, text mining | PubMed |
| The Novel Compound SIC-19 Triggers CUL4B-Mediated Ubiquitination and Degradation of SIK2. | Mol Cell Biol | 2026 | 42213109 | PubTator, text mining | PubMed |
| Ferritinophagy Rewires Carnitine-Dependent Lipid Metabolism to Inhibit PRRSV and IAV Replication. | Adv Sci (Weinh) | 2026 | 42159457 | PubTator, text mining | PubMed |
| Discovery and characterization of YSA64, a RBM39 degrader with in vivo efficacy and potent cellular activity in pediatric Ewing sarcoma A673. | Eur J Med Chem | 2026 | 42085934 | PubTator, text mining | PubMed |
| [Protein Expression Levels of the DCAF4-MEN1-hTERT Axis in Patients With Colon Adenocarcinoma and Their Relationship With Clinicopathological Characteristics and Prognosis]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2026 | 42021878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1642/papers